[TABLE OF CONTENTS]

1 INTRODUCTION OF GLOBAL NERVE REPAIR AND REGENERATION MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES

4 GLOBAL NERVE REPAIR AND REGENERATION MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS

5 GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY SURGERY
5.1 OVERVIEW
5.2 DIRECT NEUROPATHY
5.2.1 EPINEURAL REPAIR
5.2.2 PERINEURAL REPAIR
5.2.3 GROUP FASCICULAR REPAIR
5.3 NERVE GRAFTING
5.3.1 AUTOGRAFTS
5.3.2 ALLOGRAFTS
5.3.3 XENOGRAFTS
5.4 STEM CELL THERAPY
5.5 NEUROMODULATION SURGERY
5.5.1 EXTERNAL NEUROMODULATION SURGERY
5.5.2 INTERNAL NEUROMODULATION SURGERY

6 GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 BIOMATERIALS
6.2.1 NERVE CONDUITS
6.2.2 NERVE PROTECTORS
6.2.3 NERVE WRAPS
6.2.4 NERVE CONNECTORS
6.3 NEUROMODULATION SURGERY DEVICES
6.3.1 EXTERNAL NEUROMODULATION SURGERY
6.3.1.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION
6.3.1.2 TRANSCRANIAL MAGNETIC STIMULATION
6.3.2 INTERNAL NEUROMODULATION SURGERY
6.3.2.1 SPINAL CORD STIMULATION
6.3.2.2 DEEP BRAIN STIMULATION
6.3.2.3 SACRAL NERVE STIMULATION
6.3.2.4 VAGUS NERVE STIMULATION
6.3.2.5 OTHERS

7 GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY GEOGRAPHY
7.1 OVERVIEW

7.2 NORTH AMERICA
7.2.1 NORTH AMERICA MARKET SNAPSHOT
7.2.2 U.S.
7.2.3 CANADA
7.2.4 MEXICO

7.3 EUROPE
7.3.1 EUROPE MARKET SNAPSHOT
7.3.2 WESTERN EUROPE
7.3.2.1 THE UK
7.3.2.2 GERMANY
7.3.2.3 FRANCE
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF WESTERN EUROPE
7.3.3 EASTERN EUROPE
7.3.3. 1 POLAND
7.3.3.2 RUSSIA
7.3.3.3 REST OF EASTERN EUROPE

7.4 ASIA PACIFIC
7.4.1 ASIA PACIFIC MARKET SNAPSHOT
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 INDIA
7.4.5 AUSTRALIA & NEW ZEALAND
7.4.6 ASEAN
7.4.7 REST OF ASIA PACIFIC

7.5 MIDDLE EAST & AFRICA
7.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
7.5.2 UAE
7.5.3 SAUDI ARABIA
7.5.4 SOUTH AFRICA
7.5.5 REST OF MEA

7.6 SOUTH AMERICA
7.6.1 SOUTH AMERICA MARKET SNAPSHOT
7.6.2 BRAZIL
7.6.3 ARGENTINA
7.6.4 REST OF SOUTH AMERICA

8 GLOBAL NERVE REPAIR AND REGENERATION MARKET COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPANY MARKET RANKING
8.3 KEY DEVELOPMENT STRATEGIES

9 COMPANY PROFILES

9.1 AXOGEN INCORPORATED
9.1.1 OVERVIEW
9.1.2 FINANCIAL PERFORMANCE
9.1.3 PRODUCT OUTLOOK
9.1.4 KEY DEVELOPMENTS

9.2 BAXTER INTERNATIONAL
9.2.1 OVERVIEW
9.2.2 FINANCIAL PERFORMANCE
9.2.3 PRODUCT OUTLOOK
9.2.4 KEY DEVELOPMENTS

9.3 BOSTON SCIENTIFIC INCORPORATION
9.3.1 OVERVIEW
9.3.2 FINANCIAL PERFORMANCE
9.3.3 PRODUCT OUTLOOK
9.3.4 KEY DEVELOPMENTS

9.4 CYBERONICS INCORPORATION
9.4.1 OVERVIEW
9.4.2 FINANCIAL PERFORMANCE
9.4.3 PRODUCT OUTLOOK
9.4.4 KEY DEVELOPMENTS

9.5 INTEGRA LIFESCIENCES CORPORATION
9.5.1 OVERVIEW
9.5.2 FINANCIAL PERFORMANCE
9.5.3 PRODUCT OUTLOOK
9.5.4 KEY DEVELOPMENTS

9.6 MEDTRONIC PLC
9.6.1 OVERVIEW
9.6.2 FINANCIAL PERFORMANCE
9.6.3 PRODUCT OUTLOOK
9.6.4 KEY DEVELOPMENTS

9.7 ORTHOMED S.A.S.
9.7.1 OVERVIEW
9.7.2 FINANCIAL PERFORMANCE
9.7.3 PRODUCT OUTLOOK
9.7.4 KEY DEVELOPMENTS

9.8 POLYGANICS B.V.
9.8.1 OVERVIEW
9.8.2 FINANCIAL PERFORMANCE
9.8.3 PRODUCT OUTLOOK
9.8.4 KEY DEVELOPMENTS

9.9 ST. JUDE MEDICAL
9.9.1 OVERVIEW
9.9.2 FINANCIAL PERFORMANCE
9.9.3 PRODUCT OUTLOOK
9.9.4 KEY DEVELOPMENTS

9.10 STRYKER CORPORATION
9.10.1 OVERVIEW
9.10.2 FINANCIAL PERFORMANCE
9.10.3 PRODUCT OUTLOOK
9.10.4 KEY DEVELOPMENTS